Access to antiretroviral treatment in Africa
نویسندگان
چکیده
منابع مشابه
Financing equitable access to antiretroviral treatment in South Africa
BACKGROUND While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of those in need of antiretroviral treatment (ART). South Africa is currently debating the introduction of a National Health Insurance (NHI) system. Because ...
متن کاملExpanding pediatric access to antiretroviral therapy in South Africa
To read more about this study, go to the full report, http://www.popcouncil.org/pdfs/horizons/sapedssa.pdf A rapid situational analysis of the antiretroviral (ARV) rollout in South Africa found that several ARV programs are treating children successfully. However, all institutions surveyed identified a large number of concerns and challenges that need to be overcome in order to improve care for...
متن کاملScaling up access to antiretroviral treatment in southern Africa: who will do the job?
Malawi, Mozambique, Swaziland, and South Africa have some of the highest HIV/AIDS burdens in the world. All four countries have ambitious plans for scaling-up antiretroviral treatment for the millions of HIV-positive people in the region. In January 2004, we visited these countries with the intention of directly observing the effect of AIDS, especially on health systems, to talk with policy mak...
متن کاملDo patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
Public attention and debate recently have focused on access to treatment of acquired immunodeficiency syndrome (AIDS) in poor, severely affected countries, such as those in Africa. Whether patents on antiretroviral drugs in Africa are impeding access to lifesaving treatment for the 25 million Africans with human immunodeficiency virus infection is unknown. We studied the patent statuses of 15 a...
متن کاملThe Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
AIM Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. METHODS We used a micro-simulation mo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2004
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.328.7434.241